Hero Banner of The Summit on Breakthrough Therapies for Addiction

We are actively working with an ACCME accredited organization to be able to provide CME/CE credits for this conference as a demonstration of our commitment to legitimized education in the psychedelic and breakthrough therapies space.

This pioneering conference aims to showcase the transformative potential of cutting-edge research and treatment protocols. It includes psychedelics, non-hallucinogenic compounds, neuromodulation, digital therapeutics, virtual reality, patient care, and novel integration models, all designed to expedite addiction treatment. The event will feature the latest research, delving into how these groundbreaking therapies facilitate trauma healing, promote neuroplasticity, and foster personal growth for individuals dealing with addiction. Bringing together scientists, clinicians, medical experts, policy advocates, and individuals with firsthand experience overcoming addiction through these treatments, the conference serves as a nexus for inspiring hope in advancing evidence-based approaches to innovative substance use disorder treatments. Join us to explore the promising future of aiding individuals in reclaiming their lives.

Register for the The Summit >

Woman in sofa

Speaker Highlights

Stacey Armstrong, PhD

Position: Senior Researcher, Center for Psychedelic Drug Research and Education (CPDRE)
The Ohio State University

Stacey Armstrong, PhD

Senior Researcher, Center for Psychedelic Drug Research and Education (CPDRE)
The Ohio State University

Elias Dakwar, MD

Position: Associate Professor of Clinical Psychiatry
Columbia University School of Medicine

Elias Dakwar, MD

Associate Professor of Clinical Psychiatry
Columbia University School of Medicine

Henry Elkus

Position: Founder & CEO
Helena

Henry Elkus

Founder & CEO
Helena

Allison Feduccia, PhD

Position: Psychedelic Scientist, Co-founder of Psychedelic Support, Co-Founder, Scientific Advisor, Project New Day

Allison Feduccia, PhD

Psychedelic Scientist, Co-founder of Psychedelic Support, Co-Founder, Scientific Advisor, Project New Day

Tom Feegel

Position: Co-Founder
Beond

Tom Feegel

Co-Founder
Beond

Jeremy Fox, LPC

Position: Licensed Professional Counselor (LPC), Certified Professional Counselor Supervisor (CPCS), Certified EMDR Therapist and Consultant

Jeremy Fox, LPC

Licensed Professional Counselor (LPC), Certified Professional Counselor Supervisor (CPCS), Certified EMDR Therapist and Consultant

John J. Giordano, PhD

Position: Doctor Of Humane Letters, CCJS, MAC, CAP, Advisory Board Member, Legacy Medical Blue Zone Miami, Founder, The National Institute For Holistic Addiction Studies (NIFHAS)...

Doctor Of Humane Letters, CCJS, MAC, CAP, Advisory Board Member, Legacy Medical Blue Zone Miami, Founder, The National Institute For Holistic Addiction Studies (NIFHAS), Chief Knowledge Officer, NuMind Health, Author, “How To Beat Your Addictions And Live A Quality Life”, “Proven Holistic Treatment For Addiction & Chronic Relapse”

John J. Giordano, PhD

Doctor Of Humane Letters, CCJS, MAC, CAP, Advisory Board Member, Legacy Medical Blue Zone Miami, Founder, The National Institute For Holistic Addiction Studies (NIFHAS)...

Doctor Of Humane Letters, CCJS,...

Colleen A. Hanlon, PhD

Position: Vice President, Medical & Clinical Affairs, Director, Innovation Team
BrainsWay Deep TMS

Colleen A. Hanlon, PhD

Vice President, Medical & Clinical Affairs, Director, Innovation Team
BrainsWay Deep TMS

Peter Hendricks, PhD

Position: Professor and Clinical Psychologist
University of Alabama at Birmingham

Peter Hendricks, PhD

Professor and Clinical Psychologist
University of Alabama at Birmingham

Lantie Jorandby, MD

Position: Distinguished Fellow American Psychiatric Association, Chief Medical Officer
Lakeview Health

Lantie Jorandby, MD

Distinguished Fellow American Psychiatric Association, Chief Medical Officer
Lakeview Health

Timothy McMahan King

Position: Senior Fellow, Clergy for a New Drug Policy

Timothy McMahan King

Senior Fellow, Clergy for a New Drug Policy

Shel Mann

Position: CEO and Co-Founder
FireflyVR

Shel Mann

CEO and Co-Founder
FireflyVR

Deborah Mash, PhD

Position: CEO and Founder DemeRX, Professor Emeritus, University of Miami

Deborah Mash, PhD

CEO and Founder DemeRX, Professor Emeritus, University of Miami

Nick Mercadante, JD

Position: Founder and CEO
PursueCare

Nick Mercadante, JD

Founder and CEO
PursueCare

Owen Muir, MD

Position: Interventional Brain Medicine, NIH Research, The Frontier Psychiatrists

Owen Muir, MD

Interventional Brain Medicine, NIH Research, The Frontier Psychiatrists

Danielle Nova

Position: Founder, Psychedelic Recovery and Executive Director, San Francisco Psychedelic Society

Danielle Nova

Founder, Psychedelic Recovery and Executive Director, San Francisco Psychedelic Society

Charlie Panfil

Position: Public Policy Advisor
The Daschle Group

Charlie Panfil

Public Policy Advisor
The Daschle Group

Daniel Powell

Position: CEO
Spark Biomedical

Daniel Powell

CEO
Spark Biomedical

Hunt Priest

Position: Executive Director and Founder
Ligare - A Christian Psychedelic Society

Hunt Priest

Executive Director and Founder
Ligare - A Christian Psychedelic Society

Jackie von Salm, PhD

Position: Chief Science Officer
Psilera

Jackie von Salm, PhD

Chief Science Officer
Psilera

Gino R. Santorio, FACHE, MPA

Position: President & Chief Executive Officer
Mount Sinai Medical Center

Gino R. Santorio, FACHE, MPA

President & Chief Executive Officer
Mount Sinai Medical Center

Simeon Schnapper

Position: Managing Partner
JLS Fund

Simeon Schnapper

Managing Partner
JLS Fund

Richard Seely, MD

Position: Secretary
Florida Society of Addiction Medicine

Richard Seely, MD

Secretary
Florida Society of Addiction Medicine

Michelle Weiner, DO, MPH

Position: Director of Integrative Pain Solutions
NeuroPain Centers

Michelle Weiner, DO, MPH

Director of Integrative Pain Solutions
NeuroPain Centers

Alon Z. Weizer, MD, MS

Position: Senior Vice President/Chief Medical Officer Mount Sinai Medical Center, Clinical Professor of Urology, Mount Sinai Division of Columbia University Department of Urology

Alon Z. Weizer, MD, MS

Senior Vice President/Chief Medical Officer Mount Sinai Medical Center, Clinical Professor of Urology, Mount Sinai Division of Columbia University Department of Urology

Who Should Attend

This conference is intended for psychiatrists, primary care physicians, psychologists, nurse practitioners, physician assistants, psychiatric nurses, behavioral health professionals and other healthcare professionals who seek to improve the treatment of patients with mental health disorders.

TOP 5 REASONS TO ATTEND

  1. Cutting-Edge Insights: Immerse yourself in the latest research and discussions on breakthrough therapies for addiction, including the mechanisms and therapeutic potential of Ibogaine and Noribogaine, the efficacy of Ketamine, and the promising approaches of DMT and Psilocybin. Gain a deep understanding of novel non-hallucinogenic compounds and Semaglutide, offering hope for transformative addiction treatment.
  2. Diverse Perspectives: Explore a diverse range of topics such as Substance Use Disorder for Adolescents, an Integrative Approach to Treating Veterans with Biological Injuries, and the relationship between pain and addiction. With sessions on digital therapeutics, neuromodulation, and EMDR therapy, this conference provides a comprehensive perspective on addressing addiction across different demographics and through various therapeutic modalities.
  3. Real-World Evidence: Be the first to access and analyze real-world evidence from OSU’s Ibogaine Treatment Registry, offering a unique opportunity to gain insights into the practical application and outcomes of breakthrough therapies. Evaluate the safety and efficacy of Ibogaine treatment and explore how these treatments are shaping the landscape of addiction recovery.
  4. Practical Integration Models: Learn about building integration models that support lasting recovery, emphasizing the practical aspects of implementing breakthrough therapies. From community mental health case studies to exploring the role of spirituality in addiction treatment, the conference provides actionable strategies for effectively integrating these therapies into existing frameworks.
  5. Visionary Exploration: Cap off your experience by participating in the closing session, where thought leaders and experts delve into the future of breakthrough therapies for addiction. Explore research advancements, applications, and scalability, gaining a visionary perspective that will shape the landscape of addiction treatment in the years to come. This conference is not just about the present; it’s about being part of the movement that propels the future of addiction treatment forward.

Poster Sessions

Don’t miss this opportunity to have your poster considered for The Summit on Breakthrough Therapies for Addiction which will take place in-person at the Mount Sinai Medical Center of Florida in Miami, Florida from May 15 -16, 2024. Click here to learn more.

Host Sponsor

Logo of Mount Sinai Medical Center

Sponsor

Logo of Mental Joe

Community Partners

Logo of Vilomah Foundation
Logo of The Psychedelic Pulse
Logo Southeast Coalition of Psychedelic Practitioners

Sponsorship Opportunities

About Us

MOMENTUM COMMUNITIES PBC, A PUBLIC BENEFIT CORPORATION

Momentum Communities PBC (dba Momentum PBC) is deeply committed to the psychedelic community and is incorporated as a Public Benefit Corporation, focusing on generating social and public good while operating in a responsible and sustainable manner.

Mission Statement

Our mission is to empower, educate, and inspire our global community to embrace a lifestyle of wellness and healing. Through authentic storytelling, insightful content, and a commitment to scientific integrity, we aim to demystify the world of health and wellness. Our goal is to be the leading resource for individuals seeking balance, healing, and a better understanding of their own wellness journeys, nurturing a culture of well-being and conscious living for all.

In fulfilling this mission, we are committed to honoring the cultures, traditions, and reformers who have helped pave the way for this community. We recognize the rich history and diverse perspectives that exist within the psychedelic space and seek to create a platform that respects and celebrates these contributions. Through dedicated content and community building opportunities, we aim to foster an inclusive and supportive environment that welcomes individuals from all backgrounds to come together, learn from one another, and work towards a brighter future for the psychedelic movement.

Our Pillars

Empowerment: We believe in the power of healing and wellness as a transformative process that enables individuals to reclaim their lives and thrive.

Education: We commit to providing state-of-the-art, evidence-based content, along with vibrant community-building opportunities. These offerings will cater to the diverse needs of society. We will achieve this by merging independently researched content from third-party sources with activities that foster community building and social networking.

Community: We cherish the vibrant tapestry of our existing mental health community, recognizing the strength in our diversity and unity. As we continue to foster this sense of belonging, we warmly extend our hand to those yet to join us, knowing that every voice enriches our collective journey towards healing and wellness.

Advocacy: We are committed to fostering environments that promote mental wellness, providing tools and resources that encourage holistic well-being

Compassion: Our approach is rooted in empathy, respect, and understanding, treating every individual with the dignity they deserve